A critically ill patient in (b)(6) was undergoing treatment with a molecular adsorbent recirculating system (mars) on a prisma machine and prismars kit.The patient had advanced liver failure, unconscious, intubated with respiratory support and a norepinephrine drip.During treatment, the patient had an estimated blood loss of 400 ml following an external blood leak from the prismars kit.The patient was transfused with a unit of blood following this event.It was reported the patient expired sometime later.
|